litlas
ログインアカウント作成

Martin Rowe

1979–2019 年に発表

94
論文数
18,308
被引用数
83
h 指数
93
i10 指数

被引用数

Martin Rowe の年別被引用数1981 年: 被引用 2 件1982 年: 被引用 3 件1983 年: 被引用 2 件1984 年: 被引用 6 件1985 年: 被引用 15 件1986 年: 被引用 28 件1987 年: 被引用 64 件1988 年: 被引用 65 件1989 年: 被引用 77 件1990 年: 被引用 79 件1991 年: 被引用 172 件1992 年: 被引用 214 件1993 年: 被引用 261 件1994 年: 被引用 193 件1995 年: 被引用 264 件1996 年: 被引用 225 件1997 年: 被引用 227 件1998 年: 被引用 185 件1999 年: 被引用 239 件2000 年: 被引用 196 件2001 年: 被引用 193 件2002 年: 被引用 178 件2003 年: 被引用 161 件2004 年: 被引用 114 件2005 年: 被引用 93 件2006 年: 被引用 114 件2007 年: 被引用 110 件2008 年: 被引用 87 件2009 年: 被引用 121 件2010 年: 被引用 100 件2011 年: 被引用 87 件2012 年: 被引用 81 件2013 年: 被引用 86 件2014 年: 被引用 154 件2015 年: 被引用 141 件2016 年: 被引用 93 件2017 年: 被引用 102 件2018 年: 被引用 75 件2019 年: 被引用 225 件2020 年: 被引用 198 件2021 年: 被引用 245 件2022 年: 被引用 147 件2023 年: 被引用 144 件2024 年: 被引用 162 件2025 年: 被引用 66 件2026 年: 被引用 1 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,524 件、この内訳の 32.8%イギリス: 引用元論文 542 件、この内訳の 11.7%ドイツ: 引用元論文 370 件、この内訳の 8%中国: 引用元論文 247 件、この内訳の 5.3%日本: 引用元論文 188 件、この内訳の 4.1%フランス: 引用元論文 180 件、この内訳の 3.9%イタリア: 引用元論文 160 件、この内訳の 3.4%オーストラリア: 引用元論文 146 件、この内訳の 3.1%オランダ: 引用元論文 119 件、この内訳の 2.6%カナダ: 引用元論文 118 件、この内訳の 2.5%スウェーデン: 引用元論文 114 件、この内訳の 2.5%スイス: 引用元論文 84 件、この内訳の 1.8%
0%32.8%その他 18.3%

機関

分野

  • Medicine68.8%
  • Biochemistry, Genetics and Molecular Biology18.3%
  • Immunology and Microbiology11.2%
  • Agricultural and Biological Sciences0.6%
  • Neuroscience0.4%
  • Environmental Science0.2%
  • その他0.5%

トピック

  • Viral-associated cancers and disorders17.7%
  • Lymphoma Diagnosis and Treatment10.5%
  • Immune Cell Function and Interaction6.6%
  • Cytomegalovirus and herpesvirus research5.4%
  • Parvovirus B19 Infection Studies4%
  • Herpesvirus Infections and Treatments2.3%
  • その他53.5%

共著者

全論文

検索で開く
  1. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    著者: Roland Schmitz, Ryan M. Young, Michele Ceribelli, Sameer Jhavar, Wenming Xiao, Meili Zhang, George W. Wright, Arthur L. Shaffer, Daniel J. Hodson, Eric D. Buras, Xuelu Liu, John Powell, Yandan Yang, Weihong Xu, Hong Zhao, Holger Kohlhammer, Andreas Rosenwald, Philip M. Kluin, Hans Konrad Müller‐Hermelink, German Ott, Randy D. Gascoyne, Joseph M. Connors, Lisa M. Rimsza, Elı́as Campo, Elaine S. Jaffe, Jan Delabie, Erlend B. Smeland, Martin D. Ogwang, Steven J. Reynolds, Richard I. Fisher, Rita M. Braziel, Raymond R. Tubbs, James R. Cook, Dennis D. Weisenburger, Wing C. Chan, Stefania Pittaluga, Wyndham H. Wilson, Thomas A. Waldmann, Martin Rowe, Sam M. Mbulaiteye, Alan B. Rickinson, Louis M. Staudt - Nature 2012 被引用: 920

  2. Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasion

    著者: Martin Rowe, Britt A. Glaunsinger, Daphne van Leeuwen, Jianmin Zuo, David A. Sweetman, Don Ganem, Jaap M. Middeldorp, Emmanuel J. H. J. Wiertz, Maaike E. Ressing - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 被引用: 246

  3. EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

    著者: Leah Fitzsimmons, Rachel Cartlidge, Catherine Chang, Nenad Sejic, Laura C.A. Galbraith, Chathura D. Suraweera, Deborah Croom‐Carter, Grant Dewson, Rosemary J. Tierney, Andrew Bell, C. Shannon‐Lowe, Marco J. Herold, Alan B. Rickinson, Peter M. Colman, David C.S. Huang, Andreas Strasser, Marc Kvansakul, Martin Rowe, Gemma L. Kelly - Cell Death and Differentiation 2019 被引用: 63

  4. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II

    著者: Laura L. Quinn, Luke Williams, Claire White, Calum Forrest, Jianmin Zuo, Martin Rowe - Journal of Virology 2015 被引用: 91

  5. The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation

    著者: Jianmin Zuo, Andrew Currin, Bryan D. Griffin, Claire Shannon‐Lowe, Wendy A. Thomas, Maaike E. Ressing, Emmanuel J. H. J. Wiertz, Martin Rowe - PLoS Pathogens 2009 被引用: 207

  6. Epstein-Barr Virus gp42 Is Posttranslationally Modified To Produce Soluble gp42 That Mediates HLA Class II Immune Evasion

    著者: Maaike E. Ressing, Daphne van Leeuwen, Frank A. W. Verreck, Sinéad E. Keating, Raquel Gomez, Kees L. M. C. Franken, Tom H. M. Ottenhoff, Melanie K. Spriggs, Ton N. Schumacher, Lindsey Hutt‐Fletcher, Martin Rowe, Emmanuel J. H. J. Wiertz - Journal of Virology 2004 被引用: 100

  7. Epstein Barr virus entry; kissing and conjugation

    著者: Claire Shannon‐Lowe, Martin Rowe - Current Opinion in Virology 2014 被引用: 84

  8. Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection

    著者: Claire Shannon‐Lowe, Martin Rowe - PLoS Pathogens 2011 被引用: 118

  9. An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link

    著者: Gemma L. Kelly, Heather M. Long, Julianna Stylianou, Wendy A. Thomas, Alison M. Leese, Andrew Bell, Georg W. Bornkamm, Josef Mautner, Alan B. Rickinson, Martin Rowe - PLoS Pathogens 2009 被引用: 172

  10. Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products

    著者: Maaike E. Ressing, Daniëlle Horst, Bryan D. Griffin, Judy Tellam, Jianmin Zuo, Rajiv Khanna, Martin Rowe, Emmanuel J. H. J. Wiertz - Seminars in Cancer Biology 2008 被引用: 127

  11. Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death

    著者: S. A. Henderson, Martin Rowe, C D Gregory, Debbie Croom-Carter, Fred Wang, Richard Longnecker, Elliott Kieff, Alan B. Rickinson - Cell 1991 被引用: 1,189

  12. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death.

    著者: S. A. Henderson, David Huen, Martin Rowe, Chris Dawson, George S. Johnson, Alan B. Rickinson - National Academy of Sciences, Proceedings of the National Academy of Sciences 1993 被引用: 602

  13. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

    著者: David Huen, S A Henderson, Debbie Croom-Carter, Martin Rowe - 1995 被引用: 463

  14. HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 + Population

    著者: Pedro O. de Campos‐Lima, Riccardo Gavioli, Qian-Jin Zhang, Lesley E. Wallace, Riccardo Dolcetti, Martin Rowe, Alan B. Rickinson, Maria G. Masucci - Science 1993 被引用: 258

  15. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers

    著者: Martin Rowe, M. Peng-Pilon, David Huen, Rich Hardy, Debbie Croom-Carter, Erik Lundgren, Alan B. Rickinson - Journal of Virology 1994 被引用: 202

  16. The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways

    著者: Jianmin Zuo, Laura L. Quinn, Jennifer Tamblyn, Wendy A. Thomas, Regina Feederle, Henri‐Jacques Delecluse, Andrew D. Hislop, Martin Rowe - Journal of Virology 2010 被引用: 95

  17. Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle

    著者: Nathan P. Croft, Claire Shannon‐Lowe, Andrew Bell, Daniëlle Horst, Elisabeth Kremmer, Maaike E. Ressing, Emmanuel J. H. J. Wiertz, Jaap M. Middeldorp, Martin Rowe, Alan B. Rickinson, Andrew D. Hislop - PLoS Pathogens 2009 被引用: 95

  18. Epstein-Barr virus and Burkitt lymphoma

    著者: Martin Rowe, Leah Fitzsimmons, Andrew Bell - Chinese Journal of Cancer 2014 被引用: 83

  19. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

    著者: R J Murray, Michael G. Kurilla, Jill Brooks, Wendy A. Thomas, Martin Rowe, E Kieff, Alan B. Rickinson - The Journal of Experimental Medicine 1992 被引用: 506

  20. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

    著者: F Wang, Christopher D. Gregory, Martin Rowe, A. B. Rickinson, D Wang, Mark Birkenbach, Hitoshi Kikutani, Tadamitsu Kishimoto, Elliott Kieff - National Academy of Sciences, Proceedings of the National Academy of Sciences 1987 被引用: 392

  21. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

    著者: Martin Rowe, Andrea Lear, Debbie Croom-Carter, Adam Davies, Alan B. Rickinson - Journal of Virology 1992 被引用: 358

  22. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

    著者: C D Gregory, Martin Rowe, Alan B. Rickinson - Journal of General Virology 1990 被引用: 339

  23. Epstein – Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors

    著者: Aristides G. Eliopoulos, Maria Stack, William O. Dawson, Kenneth M. Kaye, Liz Hodgkin, Sim K. Sihota, Martin Rowe, Lawrence S. Young - Oncogene 1997 被引用: 258

  24. Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53

    著者: Gemma L. Kelly, Stephanie Grabow, Stefan Glaser, Leah Fitzsimmons, Brandon J. Aubrey, Toru Okamoto, Liz J. Valente, Mikara Robati, Lin Tai, W. Douglas Fairlie, Erinna F. Lee, Mikael S. Lindström, Klas G. Wiman, David C.S. Huang, Philippe Bouillet, Martin Rowe, Alan B. Rickinson, Marco J. Herold, Andreas Strasser - Genes & Development 2014 被引用: 169